Fahimeh Moradi obtained a PharmD at Mazandaran University of Medical Sciences in 2006 (Iran). For the research activities during her studies she obtained the Youth Award of Excellence 2006 (Youth National Organization). She followed her research interests in the field of Pharmacognosy at Tehran University of Medical Sciences (2006-2012, Iran) which yielded several publications in peer reviewed journals. Fahimeh was a visiting scientist at the Institute of Pharmaceutical Biology/University of Basel for one year and in March 2014 she joined the research group as a PhD student.
|Jähne, EA; Eigenmann, DE; Moradi-Afrapoli, F; Verjee, S; Butterweck, V; Hebeisen, S; Hettich, T; Schlotterbeck, G; Smiesko, M; Hamburger, M; Oufir, M: Caco-2 permeability studies and hERG liability assessment of tryptanthrin and indolinone, in: Planta Med. 82, 2016, S. 1192-1201.|
|Zabela, V; Sampath, C; Oufir, M; Moradi-Afrapoli, F; Butterweck, V; Hamburger, M: Pharmacokinetics and metabolism of dietary kaempferol and its metabolite 4-hydroxy-phenylacetic acid in rats, in: Fitoterapia 115, 2016, S. 189-197.|
|Moradi-Afrapoli, Fahimeh; Oufir, Mouhssin; Walter, Fruzsina R.; Deli, Maria A.: Validation of UHPLC-MS/MS methods for the determination of kaempferol and its metabolite 4-hydroxyphenyl acetic acid, and application to in vitro BBB and intestinal drug permeability studies, in: Journal of pharmaceutical and biomedical analysis 128, 2016, S. 264-274. edoc|